Published April 9, 2024
| Version v1
Figure
Open
Fig. 4 in Considering ivermectin for treatment of schistosomiasis
Creators
- 1. Department of Microbiology and Molecular Genetics, Kuvin Center for the Study of Infectious and Tropical Diseases, The Hebrew University - Hadassah Medical Center, Jerusalem, Israel
- 2. Department of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Description
Fig. 4 Liver transverse sections of schistosome-infected mice treated with ivermectin, DMSO vehicle, or artemisone on days 21, 22, 41, and 42 postinfection
Notes
Published as part of Golenser, Jacob, Birman, Ida & Gold, Daniel, 2024, Parasitology Research (180) 123 (4) on page 180, DOI: 10.1007/s00436-024-08178-1, http://zenodo.org/record/11376871
Files
figure.png
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:8625326f5542d299a96ddce0bab471f1
|
1.3 MB | Preview Download |
Linked records
Oops! Something went wrong while fetching results.
Additional details
Related works
- Is part of
- Journal article: 10.1007/s00436-024-08178-1 (DOI)
- Journal article: urn:lsid:plazi.org:pub:B766AC29A47FFF8EB221FFDCFFE6FFF0 (LSID)
- Journal article: https://zenodo.org/record/11376871 (URL)